RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold

Page 2 of 8 – SEC Filing

CUSIP No. M2239P109					13G
	1.	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). RA Capital Management, LLC
	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)	¨
		(b)	¨
	3.	SEC Use Only
	4.	Citizenship or Place of Organization         Massachusetts
Number of Shares Beneficially Owned by Each Reporting Person With			5.	Sole Voting Power                           0 shares
			6.	Shared Voting Power            1,308,234 shares
			7.	Sole Dispositive Power                 0 shares
			8.	Shared Dispositive Power      1,308,234 shares
	9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,308,234 shares
	10.	Check if the Aggregate Amount in Row (9) Excludes ¨ Certain Shares (See Instructions)
	11.	Percent of Class Represented by Amount in Row (9) 4.7%1
	12.	Type of Reporting Person (See Instructions) IA

 

___________________________________

¹ The reporting person is the beneficial owner of
1,308,234 ordinary shares of the Issuer which constitute approximately 4.7% of the Issuer’s outstanding ordinary shares.
The percentage calculation assumes that there are currently 27,560,920 outstanding ordinary shares of the Issuer, based on the
Issuer’s Form 20-F as filed with the Securities and Exchange Commission (“SEC”) on March 4, 2016.

 

Follow Arcturus Therapeutics Ltd. (NASDAQ:ARCT)

Follow Arcturus Therapeutics Ltd. (NASDAQ:ARCT)

Receive real-time insider trading and news alerts

---

or

Subscribe with Google

We may use your email to send marketing emails about our services. Click here to read our privacy policy.